Emily Friedland

Emily Friedland has a strong background in clinical research and operations. Emily is currently working as the Vice President of Clinical Research at DCN Dx. Prior to this, they held the position of Director, Global Clinical Operations at Teleflex Incorporated from October 2019 to August 2021. Emily also worked at Singulex, where they served as Sr. Director, Clinical and Regulatory Affairs from November 2018 to June 2019, and as Director of Clinical Affairs from November 2014 to October 2018. Before joining Singulex, they were the Associate Director of Clinical Affairs at Grifols Diagnostic Solutions from April 2011 to November 2014. Emily started their career at Roche Molecular Systems as a Manager of Clinical Research from June 1999 to January 2009, and later worked as Manager, Clinical Affairs at Celera from January 2009 to April 2011.

Emily Friedland attended Virginia Tech from 1994 to 1998, where they completed their Bachelor of Science degree in Biology.